Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Classification of systemic vasculitides].

L Guillevin1

  • 1Service de médecine interne Hôpital Avicenne Université Paris-Nord 93009 Bobigny.

La Revue Du Praticien
|April 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycobacterium chelonae infection under adalimumab therapy for spondylarthritis.

Clinical and experimental rheumatology·2010
Same author

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Annals of the rheumatic diseases·2009
Same author

Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients.

Clinical and experimental rheumatology·2009
Same author

[The tree hiding the forest].

Medecine et maladies infectieuses·2009
Same author

Progress in systemic sclerosis: a 10-year perspective.

Rheumatology (Oxford, England)·2009
Same author

Vasculopathy and pulmonary arterial hypertension.

Rheumatology (Oxford, England)·2009

Systemic vasculitis classification has evolved, with antineutrophil cytoplasmic antibodies (ANCA) now crucial for differentiating medium-vessel vasculitis like polyarteritis nodosa from small-vessel vasculitis such as microscopic polyangiitis.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Context:

  • Established classification systems for systemic vasculitides include the Chapel Hill nomenclature, ACR criteria, and Lie's classification.
  • These systems have limitations, highlighting the need for refined diagnostic approaches.
  • Antineutrophil cytoplasmic antibodies (ANCA) have emerged as a significant factor in vasculitis classification.

Purpose:

  • To evaluate the impact of ANCA on distinguishing between different types of systemic vasculitis.
  • To clarify the diagnostic utility of ANCA in differentiating medium-vessel from small-vessel vasculitides.

Summary:

  • The acceptance of ANCA's role has improved the ability to distinguish vasculitis affecting medium-caliber vessels from those affecting small vessels.

Related Experiment Videos

  • This distinction is critical for differentiating conditions like polyarteritis nodosa (medium-vessel vasculitis) from microscopic polyangiitis (small-vessel vasculitis).
  • Polyarteritis nodosa typically involves medium-sized arteries, potentially causing vascular nephropathy and organ ischemia.
  • Microscopic polyangiitis can manifest as glomerulonephritis and pulmonary capillaritis.

    • Impact:

    • Enhanced diagnostic accuracy for systemic vasculitides.
    • Improved understanding of the distinct pathologies and clinical manifestations of polyarteritis nodosa and microscopic polyangiitis.
    • Facilitates more targeted treatment strategies based on precise vasculitis classification.